Indian Pharma Sector

The Indian Pharmaceutical Sector.

Today I am writing a small article on the Indian Pharma Sector. The Indian Pharmaceutical Sector is being claimed as one of the fastest growing sectors in India. The Indian pharmaceutical industries continue to expand rapidly. In 2011 it was valued at $15 billion. It has now been estimated that in the year 2020 it may surpass 55 billion. The exports by Indian pharmaceutical industries were more than 8 billion US$ The pharma stocks have been termed as safe investment by many analysts. By going through some facts we do notice that this statement is fully validated. 

The performance in the past and the growth potential in the future seems to be tremendous. Indian pharma companies are eying more and more acquisitions abroad. More and more exports are done and new markets are identified. Indian companies are well settled in the domestic generic market too, which gives them tremendous opportunities for more growth. The large population in India makes it a huge market having sufficient room for many players. This is one factor why large Multi National Companies prefer to have a footing in India. Years back the industry witnessed the Japanese company Daiichi buying stake in Ranbaxy. We can certainly expect the Indian pharmaceutical industries to do well in the future. 

From the investor point of view we can take serious look at investing in Indian pharmaceutical companies Investing in this sector in selected companies can give the investors good returns.

I have listed below the t top 10 pharma Companies in India

1. Ranbaxy

2. Dr Reddy’s Laboratories
3. Cipla
4. Sun Pharma Industries
5. Lupin Labs
6. Aurobindo Pharma
7. GlaxoSmithKline Pharma
8. Cadila Healthcare
9. Aventis Pharma
10. Ipca Laboratories

In addition to the above companies there are many others that perform well in the Indian Pharmaceutical field. I shall write about them in this blog in time to come.